Evidence map›Paper›PMID 40588609›Full record

ArticleCell biochemistry and biophysics2025

3-Aminobenzamide-linked Multifunctional Nanoparticles: A Potent Strategy for Modulating PARP1 in Cervical Cancer Cells.

Fatma Necmiye Kaci, Cenk Daglioglu

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatma Necmiye KaciUniversity of Leeds, Faculty of Medicine and Health, St. James's University Hospital, Leeds, UK.ORCID http://orcid.org/0000-0003-3745-8173
Cenk DagliogluIstanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Medical Biochemistry, Fatih/Istanbul, Turkey. cenk.daglioglu@iuc.edu.tr.ORCID http://orcid.org/0000-0002-3857-2317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to chemotherapy remains a major obstacle in effective cancer treatment. To address this challenge, we developed multifunctional Fe

Indexed as

Antineoplastic AgentsBenzamidesNanoparticlesPoly (ADP-Ribose) Polymerase-1Uterine Cervical NeoplasmsApoptosisCell Line, TumorCell MovementCell ProliferationCell SurvivalCisplatinFemaleHumansMembrane Potential, MitochondrialSilicon Dioxide3-aminobenzamideAntineoplastic AgentsBenzamidesCisplatinPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Silicon DioxideCervical cancerCisplatinMultifunctional nanoparticlesPARP1

Identifiers

PMID40588609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.